✦ LIBER ✦

Intracranial gliomas in neurofibromatosis type 1

✍ Scribed by Listernick, Robert; Charrow, Joel; Gutmann, David H.

Publisher: John Wiley and Sons
Year: 1999
Tongue: English
Weight: 36 KB
Volume: 89
Category: Article
ISSN: 0148-7299
DOI: 10.1002/(sici)1096-8628(19990326)89:1<38::aid-ajmg8>3.0.co;2-m

No coin nor oath required. For personal study only.

✦ Synopsis

Optic pathway gliomas and brainstem gliomas are the predominant intracranial neoplasms associated with neurofibromatosis type 1 (NF1). Before the past 15 years, studies of optic pathway gliomas in NF1 were hampered by the inaccurate diagnosis of NF1, the unavailability of noninvasive neuroimaging techniques, and the frequent rendering of what would now be considered unnecessary, overly aggressive therapy. When studied systematically, these tumors behave in a much more benign fashion than their counterparts in children who do not have NF1. While they may cause symptoms in as many of 50% of cases, progression to the point where specific intervention is deemed necessary is unusual. Consequently, screening neuroimaging of asymptomatic patients is unwarranted. Because optic pathway tumors universally arise in children younger than 7 years of age, all such children should undergo yearly ophthalmologic evaluations and annual assessments of growth to monitor for signs of precocious puberty.

📜 SIMILAR VOLUMES

Epidemiology of neurofibromatosis type 1

✍ Friedman, J.M. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 25 KB

The prevalence of neurofibromatosis type 1 (NF1) is about 1/3,000. There are no known ethnic groups in which NF1 does not occur or is unusually common. The prevalence is somewhat higher in young children than in adults, a difference that probably results at least in part from the early death of some

Neurofibromatosis type 1 growth charts

✍ Clementi, M.; Milani, S.; Mammi, I.; Boni, S.; Monciotti, C.; Tenconi, R. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 1 views

Growth abnormalities such as macrocephaly and short stature have been described and are considered a consistent finding in neurofibromatosis type 1 (NF1), one of the most common autosomal dominant disorders in man. We present here a clinical study on the growth profile of a sample of NF1 patients co

Hyperactive Ras as a therapeutic target

Hyperactive Ras as a therapeutic target in neurofibromatosis type 1

✍ Weiss, Brian; Bollag, Gideon; Shannon, Kevin 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 38 KB

The NF1 gene encodes neurofibromin, a GTPase-activating protein (GAP) for members of the p21 ras (Ras) family, which negatively regulates Ras output by accelerating the conversion of active RasиGTP to inactive RasиGDP. Analysis of tumors from patients with neurofibromatosis type 1 (NF1) has shown bi

Neurofibromatosis 1

✍ Viskochil, Dave 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 25 KB 👁 2 views

Two independent mutations in a family wi

Two independent mutations in a family with neurofibromatosis type 1 (NF1)

✍ Klose, Anja; Peters, Hartmut; Hoffmeyer, Sven; Buske, Annegret; L�der, Andrea; H 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 39 KB

We report on two independent alterations of the NF1 gene in a three-generation kindred with neurofibromatosis type 1 (NF1). Using temperature gradient gel electrophoresis (TGGE) in a mutation analysis of exon 31 of the NF1 gene we detected the previously reported nonsense mutation R1947X. This Cto-T

RecurrentNF1 gene mutation in a patient

RecurrentNF1 gene mutation in a patient with oligosymptomatic neurofibromatosis type 1 (NF1)

✍ Buske, Annegret; Gewies, Andreas; Lehmann, R�diger; R�ther, Klaus; Algermissen, 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 10 KB 👁 1 views

We report a 21-year-old male with symptomatic optic glioma who does not fulfill the diagnosis of neurofibromatosis 1 (NF1) according to standard NIH criteria. Analysis of the NF1 gene revealed a recurrent mutation in exon 37 (C6792A or Y2264X). This nonsense mutation causes skipping of exon 37 durin